Evidence for Selective Advantage of Pathogenic FGFR2 Mutations in the Male Germ Line

Observed mutation rates in humans appear higher in male than female gametes and often increase with paternal age. This bias, usually attributed to the accumulation of replication errors or inefficient repair processes, has been difficult to study directly. Here, we describe a sensitive method to quantify substitutions at nucleotide 755 of the fibroblast growth factor receptor 2 (FGFR2) gene in sperm. Although substitution levels increase with age, we show that even high levels originate from infrequent mutational events. We propose that these FGFR2 mutations, although harmful to embryonic development, are paradoxically enriched because they confer a selective advantage to the spermatogonial cells in which they arise.

[1]  Alexey S Kondrashov,et al.  Direct estimates of human per nucleotide mutation rates at 20 loci causing mendelian diseases , 2003, Human mutation.

[2]  Kateryna Makova,et al.  Male-driven evolution. , 2002, Current opinion in genetics & development.

[3]  N. Arnheim,et al.  The observed human sperm mutation frequency cannot explain the achondroplasia paternal age effect , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[4]  A. V. D. van den Ouweland,et al.  FGFs, their receptors, and human limb malformations: clinical and molecular correlations. , 2002, American journal of medical genetics.

[5]  E. Zackai,et al.  Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis. , 2002, American journal of human genetics.

[6]  S. Antonarakis,et al.  Nomenclature for the description of human sequence variations , 2001, Human Genetics.

[7]  M. Mohammadi,et al.  Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[8]  J. G. Park,et al.  Mutations in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers. , 2001, Cancer research.

[9]  G. Waksman,et al.  Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[10]  J. Crow.  The origins, patterns and implications of human spontaneous mutation , 2000, Nature Reviews Genetics.

[11]  M. Nachman,et al.  Estimate of the mutation rate per nucleotide in humans. , 2000, Genetics.

[12]  M. Saarma,et al.  Regulation of cell fate decision of undifferentiated spermatogonia by GDNF. , 2000, Science.

[13]  M. Gonzalès,et al.  Clinical variability in patients with Apert's syndrome. , 1999, Journal of neurosurgery.

[14]  J. Heath,et al.  Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand. , 1998, Human molecular genetics.

[15]  J. A. Harris,et al.  Birth prevalence, mutation rate, sex ratio, parents' age, and ethnicity in Apert syndrome. , 1997, American journal of medical genetics.

[16]  E. Zackai,et al.  Genotype-phenotype correlation for nucleotide substitutions in the IgII-IgIII linker of FGFR2. , 1997, Human molecular genetics.

[17]  W F Bodmer,et al.  The mutation rate and cancer. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Steven A. Wall,et al.  Exclusive paternal origin of new mutations in Apert syndrome , 1996, Nature Genetics.

[19]  W. Reardon,et al.  Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome , 1995, Nature Genetics.

[20]  S. Kreiborg,et al.  Birth prevalence study of the Apert syndrome. , 1992, American journal of medical genetics.

[21]  N. Risch,et al.  Spontaneous mutation and parental age in humans. , 1987, American journal of human genetics.